首页 | 本学科首页   官方微博 | 高级检索  
     

吲哚胺2,3-双加氧酶、c-myc在膀胱尿路上皮癌中的表达及其意义
引用本文:杨承纲,叶丽娟,张丽娟. 吲哚胺2,3-双加氧酶、c-myc在膀胱尿路上皮癌中的表达及其意义[J]. 肿瘤研究与临床, 2014, 0(8): 518-522
作者姓名:杨承纲  叶丽娟  张丽娟
作者单位:云南省肿瘤医院昆明医科大学第三附属医院病理科,昆明650118
基金项目:昆明医科大学-云南省科技厅联合专项(2010CD183)
摘    要:
目的 探讨吲哚胺2,3-双加氧酶(IDO)、c-myc在膀胱尿路上皮癌中的表达及其临床意义.方法 采用荧光定量聚合酶链反应(PCR)检测新鲜肿瘤及黏膜标本各20例IDO mRNA表达,采用SP法检测肿瘤石蜡标本84例及黏膜22例IDO、c-myc蛋白的表达,分析二者与临床病理特征的关系.结果 在膀胱尿路上皮癌组织中,IDO、c-myc蛋白表达强度与患者年龄、性别无关.在浸润型膀胱尿路上皮癌组织中IDO蛋白表达高于非浸润型(x2=5.600,P=0.018),随着组织分级及国际抗癌联盟(UICC)分期增高,IDO蛋白阳性表达率增高(x2=20.268,P=0.000;x2=12.075,P=0.007).c-myc蛋白在正常膀胱组织中无阳性表达,在膀胱尿路上皮癌组织中44例(52.4%)表达阳性,二者阳性表达率差异有统计学意义(x2=10.733,P=0.001);c-myc蛋白表达强度与组织学分类、组织分级及UICC分期无关.在膀胱尿路上皮癌组织中IDO蛋白表达强度与c-myc蛋白表达强度呈正相关(r=0.205,P=0.047),与组织学分类、组织分级及UICC分期呈正相关(r=0.258,P=0.018;r=0.491,P=0.000;r=0.365,P=0.001).IDO mRNA在膀胱尿路上皮癌组织中的表达(7.696 1±1.745 2)明显高于正常膀胱组织(6.397 0±1.205 1)(t=2.367,P=0.023).Ta~T1期膀胱尿路上皮癌组织中IDO mRNA的平均表达水平为6.803 4±1.567 5,明显低于T2~T4期的9.183 8±0.690 3(t=4.955,P=0.000);IDO mRNA在Ⅰ、Ⅱ、Ⅲ级膀胱尿路上皮癌组织中的平均表达水平分别为7.058 7±1.771 5、7.934 2±1.530 5、9.290 7±0.574 5,随着分级增高而增高,差异有统计学意义(t=2.729,P=0.011).结论 IDO表达与膀胱尿路上皮癌预后不良相关,c-myc表达强度与膀胱尿路上皮癌病变进展无关,但可能与膀胱尿路上皮癌病变发生有关.IDO可能成为膀胱尿路上皮癌预后的预测因子,IDO、c-myc有可能成为肿瘤化疗的一个分子靶向目标.

关 键 词:吲哚胺2,3-双加氧酶  癌基因蛋白质c-myc  膀胱尿路上皮癌  聚合酶链反应  免疫组织化学

Expression of IDO and c-myc in bladder urothelial carcinoma and their significance
Yang Chenggang. Expression of IDO and c-myc in bladder urothelial carcinoma and their significance[J]. Cancer Research and Clinic, 2014, 0(8): 518-522
Authors:Yang Chenggang
Affiliation:Yang Chenggang(Department of Pathology, Yunnan Provincial Tumor Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China) Ye Lijuan(Department of Pathology, Yunnan Provincial Tumor Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China) Zhang Lijuan(Department of Pathology, Yunnan Provincial Tumor Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China)
Abstract:
Objective To investigate the expression and significance of IDO and c-myc in bladder urothelial carcinoma.Methods IDO mRNA expression from fresh tumor and mucosa specimens from 20 cases were detected by fluorescence quantitative PCR,and SP was used to detect the IDO,c-myc protein in paraffin-embeded specimens from 84 cases and mucosa specimens from 22 cases.Results In bladder urothelial carcinoma,IDO,c-myc protein expression level had no relationship with age and sex.Expression of IDO protein in invasive bladder urothelial carcinoma was significantly higher than that of no-invasive (x2 =5.600,P =0.018).With the increase of the histological grade (x2 =20.268,P =0.000) and UICC stage (x2 =12.075,P =0.007),the positive expression rate of IDO protein was increased.There was not positive expression of c-myc protein in normal bladder tissue,but in bladder urothelial carcinoma,44 cases (52.4 %) were positive expression (x2 =10.733,P =0.001).The expression of c-myc protein had no relationship with the histological classification,histological grade and UICC stage.In bladder urothelial carcinoma tissue,IDO protein expression level was positively correlated with c-myc protein expression (r =0.205,P =0.047),and was positively correlated with the histological classification,histological grade and UICC stage (r =0.258,P =0.018; r =0.491,P =0.000; r =0.365,P =0.001).Expression of IDO mRNA in bladder urothelial carcinoma (7.696 1±1.745 2) was significantly higher than that in normal bladder tissue (6.397 0±1.205 1)(t =2.367,P =0.023).The average expression level of IDO mRNA in bladder urothelial carcinoma of Ta-T1 stage was 6.803 4±1.567 5,which was significantly lower than that in T2-T4 stage (9.183 8±0.690 3) (t =4.955,P =0.000).The average expression levels of IDO mRNA in grade Ⅰ,Ⅱ,Ⅲ bladder urothelial carcinoma were 7.058 7±1.771 5,7.934 2±1.530 5,9.290 7±0.574 5,respectively,which were increased with the grade increasing (t =2.729,P =0.011).Conclusions The hig
Keywords:Indoleamine 2, 3-dioxygenase  Proto-oncogene proteins c-myc  Bladder urothelial carcinoma  Polymerase chain reaction  Immunohistochemistry
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号